Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
ClinicalTrials.gov study NCT04340882. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
ClinicalTrials.gov study NCT03911713. IPD Sharing: NO. Countries: 7. Publications: 1.
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
ClinicalTrials.gov study NCT04415073. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02128958. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer
ClinicalTrials.gov study NCT01053013. IPD Sharing: NO. Countries: 1. Publications: 6.
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
ClinicalTrials.gov study NCT05406479. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
ClinicalTrials.gov study NCT02905578. IPD Sharing: YES. Countries: 1. Publications: 3.
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2
ClinicalTrials.gov study NCT02551874. IPD Sharing: Not stated. Countries: 10. Publications: 1.
BRITEPath- Phase 2
ClinicalTrials.gov study NCT04672798. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
ClinicalTrials.gov study NCT02331368. IPD Sharing: Not stated. Countries: 1. Publications: 1.
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts W
ClinicalTrials.gov study NCT00818454. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
ClinicalTrials.gov study NCT00372385. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
ClinicalTrials.gov study NCT01981850. IPD Sharing: YES. Countries: 8. Publications: 1.
PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
ClinicalTrials.gov study NCT05543707. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density
ClinicalTrials.gov study NCT00715676. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00446134. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma
ClinicalTrials.gov study NCT01681212. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02096354. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
ClinicalTrials.gov study NCT02247739. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT00369681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.